Close
Nordic 9Nordic 9

StemInov (private company)

France
See something wrong or missing? Let us know
Offices:Paris
Industry:BiotechHealth services
Business model:B2B

StemInov is a startup in France developing mesenchymal stem cell-based therapies for severe inflammatory and autoimmune diseases, with a lead candidate WhartSep targeting complications from severe pneumonia.

Investors: we tracked 6 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 12.35M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to StemInov

Name Criteria
Germany Atai Life Sciences
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden EnginZyme
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Norway Mentis Cura
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Norway Oncoinvent
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Sano Genetics
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Sigrid Therapeutics
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Netherlands Leyden Labs
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Mogrify
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Top